Synthetic cannabinoid-induced psychotic disorder

Synthetic cannabinoid-induced psychotic disorder is characterized by psychotic symptoms (e.g., delusions, hallucinations, disorganized thinking, grossly disorganized behavior) that develop during or soon after intoxication with or withdrawal from synthetic cannabinoids. The intensity or duration of the symptoms is substantially in excess of psychotic-like disturbances of perception, cognition, or behavior that are characteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount and duration of synthetic cannabinoid use must be capable of producing psychotic symptoms. The symptoms are not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the case if the psychotic symptoms preceded the onset of the synthetic cannabinoid use, if the symptoms persist for a substantial period of time after cessation of the synthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with psychotic symptoms (e.g., a history of prior episodes not associated with synthetic cannabinoid use).

ICD-11 diagnostic criteria

• objawy psychotyczne
• związek czasowy z używaniem syntetycznych kannabinoidów

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid-induced psychotic disorder are:

• omamy
• urojenia

Differential diagnosis

When diagnosing Synthetic cannabinoid-induced psychotic disorder, the following ICD-11 disorders should be considered in the differential diagnosis:

• Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41)

Frequently asked questions

How is Synthetic cannabinoid-induced psychotic disorder diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Synthetic cannabinoid-induced psychotic disorder (6C42.6) include: objawy psychotyczne; związek czasowy z używaniem syntetycznych kannabinoidów.

What disorders are in the differential diagnosis of Synthetic cannabinoid-induced psychotic disorder?

The differential diagnosis of Synthetic cannabinoid-induced psychotic disorder (6C42.6) includes: Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.6 – WHO ICD-11

Notes

Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną